Periurethral and Intravenous Injections of Adipose-Derived Stem Cells to Promote Local Tissue Recovery in a Rat Model of Stress Urinary Incontinence

Urology. 2022 Sep:167:82-89. doi: 10.1016/j.urology.2022.05.018. Epub 2022 May 30.

Abstract

Objective: To compare the effects of periurethral and intravenous injection of adipose-derived stem cells (ADSCs) on voiding function and tissue recovery in a stress urinary incontinence (SUI) rat model.

Methods: Sixty-four postpartum rats were randomly allocated to a normal group and the SUI model was established in 48 rats by vagina balloon dilation and bilateral ovariectomy. The SUI rats were randomized into 3 groups and received urethral injection of PBS (SUI group), periurethral injection of ADSCs (PU group), and intravenous injection of ADSCs (IV group) in 10 days after the ovariectomy. After 1, 7, and 14 days, ADSCs were tracked in urethra specimen. The urinary function of the remaining rats was analyzed at day 28, and urethral tissues were harvested for Western blotting and histochemical analyses.

Results: Alpha smooth muscle actin, myosin heavy chain, vascular endothelial growth factor, and neurofilament protein expression was increased in the IV and PU groups. Voiding function was also improved, with no significant differences between the IV and PU groups. The cell retention rate in rat urethral tissues was higher in the PU group than that in the IV group. Compared with the IV group, myosin heavy chain, vascular endothelial growth factor, neurofilament and transforming growth factor-β1 (TGF-β1)/Smad pathway protein expression levels were significantly higher in the PU group, while alpha smooth muscle actin expression was significantly lower (P < .05).

Conclusion: Periurethral and intravenous injection of ADSCs induces different degrees of recovery of the urethral sphincter, cytokine secretion levels and cell retention rates in the urethral tissues in SUI rats, however, there was no significant difference in 2 methods.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Female
  • Injections, Intravenous
  • Myosin Heavy Chains / metabolism
  • Myosin Heavy Chains / pharmacology
  • Neurofilament Proteins / metabolism
  • Neurofilament Proteins / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Stem Cells / metabolism
  • Transforming Growth Factor beta1 / metabolism
  • Urethra
  • Urinary Incontinence, Stress*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Actins
  • Neurofilament Proteins
  • Transforming Growth Factor beta1
  • Vascular Endothelial Growth Factor A
  • Myosin Heavy Chains